logo

FDA Calendar

Share
Company Name Sanofi
Drug Name Sutimlimab (BLA)
Event Name FDA decision on Sutimlimab for the treatment of hemolysis in adult patients with cold agglutinin disease
Event Date 11/13/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar